bencyclane has been researched along with Coronary Disease in 2 studies
Bencyclane: A vasodilator agent found to be effective in a variety of peripheral circulation disorders. It has various other potentially useful pharmacological effects. Its mechanism may involve block of calcium channels.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Széplaki, S | 2 |
| Grasser, K | 1 |
| Petócz, L | 1 |
| Széplaki, Z | 1 |
2 other studies available for bencyclane and Coronary Disease
| Article | Year |
|---|---|
[New data on the mechanism of cardiac action of bencyclane (Fludilat)].
Topics: Adolescent; Adult; Angina Pectoris; Animals; Bencyclane; Cats; Coronary Disease; Cycloheptanes; Elec | 1978 |
[Fludilat treatment of vagotonic and subendocardial disturbances of cardiac metabolism and bradycardiac coronary diseases (author's transl)].
Topics: Acute Disease; Adult; Aged; Bencyclane; Bradycardia; Chronic Disease; Coronary Circulation; Coronary | 1976 |